Buy IMARA Stock | IMRA Stock Price & Latest News | Public.com
IMRA

IMARA

$0.00 (0.00%)Today
    View IMARA (IMRA) stock trends here

    About IMRA

    Imara, Inc. is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. Its product candidate, IMR-687 is a selective and small molecule inhibitor of PDE9. ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.3
    -0.59
    -0.89
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.89

    Actual EPS
    Q2 2021

    Stats

    Market Cap$121,62M
    Volume66,09k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$62.71
    1 Year Low$6.85
    Open$7.35
    High$7.38
    Low$6.85

    Buy any stock with any amount of money.

    Download the App
    Download the app